Company Filing History:
Years Active: 2012-2014
Title: Innovations in Diabetes and Obesity Treatment by James F List
Introduction
James F List, based in Princeton, NJ, is a prominent inventor recognized for his contributions in the field of pharmaceuticals, particularly focusing on obesity and diabetes treatment. With a total of three patents to his name, he is dedicated to developing innovative therapeutic strategies that promise to change the lives of many patients who struggle with these conditions.
Latest Patents
James F List's latest patents include groundbreaking methods aimed at addressing significant health issues related to obesity and insulin resistance. One of his notable inventions is focused on "Methods for treating obesity employing an SGLT2 inhibitor." This patent outlines a method for administering a therapeutically effective amount of an SGLT2 inhibitor alone or in combination with another anti-obesity agent to facilitate weight loss in mammalian subjects. It also discusses a pharmaceutical composition that incorporates these inhibitors, highlighting the potential for improved treatment outcomes.
Another significant patent is titled "Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof." This invention offers new treatment avenues for patients with type 2 diabetes who have not responded well to prior medications. It emphasizes the utilization of therapeutic agents, alongside SGLT2 inhibitors, to enhance the effectiveness of diabetes management.
Career Highlights
Throughout his career, James has held influential positions in leading pharmaceutical companies, including Bristol-Myers Squibb Company and AstraZeneca AB. His work there has involved extensive research and development efforts that contribute to the advancement of treatment for chronic diseases.
Collaborations
In his journey, James has collaborated with notable colleagues like William N Washburn and Jean Whaley. These partnerships have helped in the exchange of ideas and fostered innovation, further solidifying his impact in the pharmaceutical realm.
Conclusion
James F List's innovative approaches in treating obesity and diabetes demonstrate his commitment to improving patient health outcomes. With a robust portfolio of patents and a history of collaboration in reputable companies, he is an influential figure in biomedical advancements. His ongoing work continues to pave the way for future innovations in the treatment of chronic diseases.